| Filed | As-Of/On | Form | Fullname | Fund Class | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypotheticals Return |
Hypotheticals Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-11-06 | 2009-09-30 | 13F-HR | Chwab Charles Investment Management Inc | Institution | 54,100 | No Change | 0 | 0 % | $400,340 | $400,340 | $0 | 0.00 % | $0 | | | | | | News Article | History of Chwab Charles Investment Management Inc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Credit Suisse First Boston | Institution | 94,202 | Added More | 49,682 | 111.59 % | $697,095 | $697,095 | $0 | 0.00 % | $0 | | | | | | News Article | History of Credit Suisse First Boston Ownership Of Rigel Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Metropolitan Life Insurance Co | Institution | 36,920 | No Change | 0 | 0 % | $273,208 | $273,208 | $0 | 0.00 % | $0 | | | | | | News Article | History of Metropolitan Life Insurance Co Ownership Of Rigel Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Pnc Financial Services Group Inc | Institution | 593 | Sold Some | -193 | -24.55 % | $4,388 | $4,388 | $0 | 0.00 % | $0 | | | | | | News Article | History of Pnc Financial Services Group Inc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Teachers Advisors Inc | Institution | 40,558 | Added More | 9,670 | 31.30 % | $300,129 | $300,129 | $0 | 0.00 % | $0 | | | | | | News Article | History of Teachers Advisors Inc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Tiaa Cref Investment Management Llc | Institution | 266,208 | Added More | 55,500 | 26.33 % | $1,969,939 | $1,969,939 | $0 | 0.00 % | $0 | | | | | | News Article | History of Tiaa Cref Investment Management Llc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-11-06 | 2009-08-31 | N-CSR | Valic Co Ii-Small Cap Value Fund | Small-Cap Value | | Sold All | -36,600 | -100 % | | | | 0.00 % | $0 | | | | | | News Article | History of Valic Co Ii-Small Cap Value Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Bank Of Hawaii | Institution | 20,189 | Sold Some | -5,200 | -20.48 % | $146,572 | $149,399 | $2,826 | 1.92 % | $-728 | | | | | | News Article | History of Bank Of Hawaii Ownership Of Rigel Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Parametric Portfolio Associate | Institution | 14,603 | Sold Some | -2,104 | -12.59 % | $106,018 | $108,062 | $2,044 | 1.92 % | $-295 | | | | | | News Article | History of Parametric Portfolio Associate Ownership Of Rigel Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Proshare Advisors Llc | Institution | | Sold All | -14,417 | -100 % | | | | 1.92 % | $-2,018 | | | | | | News Article | History of Proshare Advisors Llc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Rafferty Asset Management Llc | Institution | 35,361 | No Change | 0 | 0 % | $256,721 | $261,671 | $4,951 | 1.92 % | $0 | | | | | | News Article | History of Rafferty Asset Management Llc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-11-04 | 2009-08-31 | N-CSR | Ga Funds-Ssga Enhanced Small Cap Fund | Small-Cap Core | 500 | New Holding | 500 | 100 % | $3,550 | $3,700 | $150 | 4.22 % | $150 | | | | | | News Article | History of Ga Funds-Ssga Enhanced Small Cap Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-11-04 | 2009-08-31 | N-CSRS | Gmo Trust-Gmo Value Fund | Multi-Cap Value | | Sold All | -400 | -100 % | | | | 4.22 % | $-120 | | | | | | News Article | History of Gmo Trust-Gmo Value Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | M And T Bank Corp | Institution | | Sold All | -30,550 | -100 % | | | | 2.63 % | $-5,805 | | | | | | News Article | History of M And T Bank Corp Ownership Of Rigel Pharmaceuticals Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR/A | Penn Mutual Life Insurance Co | Institution | 11,459 | New Holding | 11,459 | 100 % | $75,056 | $84,797 | $9,740 | 12.97 % | $9,740 | | | | | | News Article | History of Penn Mutual Life Insurance Co Ownership Of Rigel Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios-Pharmaceuticals Portfolio | Health/Biotech | 5,000 | No Change | 0 | 0 % | $32,750 | $37,000 | $4,250 | 12.97 % | $0 | | | | | | News Article | History of Fidelity Select Portfolios-Pharmaceuticals Portfolio Ownership Of Rigel Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios-Technology Portfolio | Science & Tech | 163,565 | Sold Some | -9,000 | -5.21 % | $1,071,351 | $1,210,381 | $139,030 | 12.97 % | $-7,650 | | | | | | News Article | History of Fidelity Select Portfolios-Technology Portfolio Ownership Of Rigel Pharmaceuticals Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Oxford Asset Management | Institution | 98,236 | New Holding | 98,236 | 100 % | $629,693 | $726,946 | $97,254 | 15.44 % | $97,254 | | | | | | News Article | History of Oxford Asset Management Ownership Of Rigel Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Advisor Series I-Growth Opportunities Fund | Large-Cap Core | 348,900 | Added More | 24,294 | 7.48 % | $2,236,449 | $2,581,860 | $345,411 | 15.44 % | $24,051 | | | | | | News Article | History of Fidelity Advisor Series I-Growth Opportunities Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Commonwealth Trust-Fidelity Nasdaq Composite Index Tracking Stock | Specialty & Misc | 1,551 | No Compare | | | $9,942 | $11,477 | $1,535 | 15.44 % | | | | | | | News Article | History of Fidelity Commonwealth Trust-Fidelity Nasdaq Composite Index Tracking Stock Ownership Of Rigel Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-CSR | Vanguard World Fund-Vanguard Health Care Index Fund | Health/Biotech | 16,862 | New Holding | 16,862 | 100 % | $108,085 | $124,779 | $16,693 | 15.44 % | $16,693 | | | | | | News Article | History of Vanguard World Fund-Vanguard Health Care Index Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Dimensional Fund Advisors Inc | Institution | 621,731 | Added More | 3,500 | 0.56 % | $3,860,950 | $4,600,809 | $739,860 | 19.16 % | $4,165 | | | | | | News Article | History of Dimensional Fund Advisors Inc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I-Health Sciences Fund | Health/Biotech | 11,100 | Sold Some | -7,300 | -39.67 % | $68,931 | $82,140 | $13,209 | 19.16 % | $-8,687 | | | | | | News Article | History of Valic Co I-Health Sciences Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I-Small Cap Index Fund | Small-Cap Core | 29,716 | New Holding | 29,716 | 100 % | $184,536 | $219,898 | $35,362 | 19.16 % | $35,362 | | | | | | News Article | History of Valic Co I-Small Cap Index Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-10-28 | 2009-08-31 | N-Q | Dws Securities Trust-Dws Health Care Fund | Health/Biotech | 28,300 | No Change | 0 | 0 % | $172,064 | $209,420 | $37,356 | 21.71 % | $0 | | | | | | News Article | History of Dws Securities Trust-Dws Health Care Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Inc | No Data | | Sold All | -208,446 | -100 % | | | | 6.62 % | $-95,885 | | | | | | News Article | History of Blackrock Inc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Fidelity Advisor Series Vii-Fidelity Advisor Biotechnology Fund | Health/Biotech | 15,270 | Added More | 7,635 | 100.00 % | $109,333 | $112,998 | $3,665 | 3.35 % | $1,832 | | | | | | News Article | History of Fidelity Advisor Series Vii-Fidelity Advisor Biotechnology Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Profunds-Bull Profund | Large-Cap Core | 1,484 | Added More | 735 | 98.13 % | $10,625 | $10,982 | $356 | 3.35 % | $176 | | | | | | News Article | History of Profunds-Bull Profund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Pacific Capital Funds-Small Cap Fund | Small-Cap Value | 24,789 | Sold Some | -15,000 | -37.69 % | $179,224 | $183,439 | $4,214 | 2.35 % | $-2,550 | | | | | | News Article | History of Pacific Capital Funds-Small Cap Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Aim Investment Funds-Aim Developing Markets Fund | Emerging Markets | 201,608 | New Holding | 201,608 | 100 % | $1,659,234 | $1,491,899 | $-167,335 | -10.08 % | $-167,335 | | | | | | News Article | History of Aim Investment Funds-Aim Developing Markets Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc-International Core Equity Portfolio | International Small-Mid-Cap Value | 35,400 | Added More | 2,400 | 7.27 % | $291,342 | $261,960 | $-29,382 | -10.08 % | $-1,992 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc-International Core Equity Portfolio Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc-International Vector Equity Portfolio | No Data | 15,304 | Added More | 2,800 | 22.39 % | $125,952 | $113,250 | $-12,702 | -10.08 % | $-2,324 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc-International Vector Equity Portfolio Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc-Us Sustainability Core 1 Portfolio | No Data | 700 | No Change | 0 | 0 % | $5,761 | $5,180 | $-581 | -10.08 % | $0 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc-Us Sustainability Core 1 Portfolio Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Eligman Global Fund Series Inc-Global Smaller Companies Fund | Global Small/Mid-Cap Core | 53,654 | Sold Some | -3,500 | -6.12 % | $441,572 | $397,040 | $-44,533 | -10.08 % | $2,905 | | | | | | News Article | History of Eligman Global Fund Series Inc-Global Smaller Companies Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Jnl Investors Series Trust-Jackson Perspective Index 5 Fund | Specialty & Misc | 657 | No Change | 0 | 0 % | $5,407 | $4,862 | $-545 | -10.08 % | $0 | | | | | | News Article | History of Jnl Investors Series Trust-Jackson Perspective Index 5 Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds-Massmutual Premier Main Street Small Cap Fund | Small-Cap Core | | Sold All | -3,330 | -100 % | | | | -10.73 % | $2,964 | | | | | | News Article | History of Massmutual Premier Funds-Massmutual Premier Main Street Small Cap Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds-Massmutual Premier Small Company Opportunities Fund | Small-Cap Core | | Sold All | -6,000 | -100 % | | | | -10.73 % | $5,340 | | | | | | News Article | History of Massmutual Premier Funds-Massmutual Premier Small Company Opportunities Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Old Westbury Funds Inc-International Fund | International Multi-Cap Core | 6,300 | No Change | 0 | 0 % | $52,227 | $46,620 | $-5,607 | -10.73 % | $0 | | | | | | News Article | History of Old Westbury Funds Inc-International Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Powershares Exchange Traded Fund Trust-Powershares Dynamic Small Cap Growth Portfolio | Small-Cap Growth | 610 | New Holding | 610 | 100 % | $5,057 | $4,514 | $-543 | -10.73 % | $-543 | | | | | | News Article | History of Powershares Exchange Traded Fund Trust-Powershares Dynamic Small Cap Growth Portfolio Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Powershares Exchange-Traded Fund Trust Ii-Powershares Global Biotech Portfolio | No Data | 831 | Added More | 31 | 3.87 % | $6,889 | $6,149 | $-740 | -10.73 % | $-28 | | | | | | News Article | History of Powershares Exchange-Traded Fund Trust Ii-Powershares Global Biotech Portfolio Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Direxion Shares Etf Trust-Direxion Daily Small Cap Bull 3x Shares | No Data | 29,960 | New Holding | 29,960 | 100 % | $248,968 | $221,704 | $-27,264 | -10.95 % | $-27,264 | | | | | | News Article | History of Direxion Shares Etf Trust-Direxion Daily Small Cap Bull 3x Shares Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Mtb Group Of Funds-Mtb Multi Cap Growth Fund | Multi-Cap Core | 1,925 | Added More | 1,525 | 381.25 % | $15,997 | $14,245 | $-1,752 | -10.95 % | $-1,388 | | | | | | News Article | History of Mtb Group Of Funds-Mtb Multi Cap Growth Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Mtb Group Of Funds-Mtb Small Cap Growth Fund | Small-Cap Growth | 98,000 | New Holding | 98,000 | 100 % | $814,380 | $725,200 | $-89,180 | -10.95 % | $-89,180 | | | | | | News Article | History of Mtb Group Of Funds-Mtb Small Cap Growth Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-22 | 2009-07-31 | N-Q | Dreyfus Premier Opportunity Funds-Health Care Fund | Health/Biotech | 17,240 | Added More | 10,050 | 139.77 % | $138,954 | $127,576 | $-11,378 | -8.18 % | $-6,633 | | | | | | News Article | History of Dreyfus Premier Opportunity Funds-Health Care Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-17 | 2009-07-31 | N-Q | Rydex Etf Trust-Rydex Inverse Russell 2000 Etf | Specialty & Misc | 790 | New Holding | 790 | 100 % | $6,012 | $5,846 | $-166 | -2.75 % | $-166 | | | | | | News Article | History of Rydex Etf Trust-Rydex Inverse Russell 2000 Etf Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Jpmorgan Trust Ii-Jpmorgan Technology Fund | Science & Tech | 6 | New Holding | 6 | 100 % | $42 | $44 | $2 | 5.26 % | $2 | | | | | | News Article | History of Jpmorgan Trust Ii-Jpmorgan Technology Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Series Funds-Banking Fund | Financial Services | 986 | Sold Some | -184 | -15.72 % | $6,932 | $7,296 | $365 | 5.26 % | $-68 | | | | | | News Article | History of Rydex Series Funds-Banking Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Variable Trust-Biotechnology Fund | Health/Biotech | 17,767 | Sold Some | -10,362 | -36.83 % | $124,902 | $131,476 | $6,574 | 5.26 % | $-3,834 | | | | | | News Article | History of Rydex Variable Trust-Biotechnology Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-04 | 2009-08-17 | N-CSR | John Hancock Trust-Health Sciences Trust | Health/Biotech | | Sold All | -18,300 | -100 % | | | | 8.66 % | $-10,797 | | | | | | News Article | History of John Hancock Trust-Health Sciences Trust Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Advanced Series Trust-Ast Federated Aggressive Growth Portfolio | Multi-Cap Growth | 69,685 | Added More | 41,500 | 147.24 % | $474,555 | $515,669 | $41,114 | 8.66 % | $24,485 | | | | | | News Article | History of Advanced Series Trust-Ast Federated Aggressive Growth Portfolio Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Axa Premier Vip Trust-Multimanager Small Cap Growth Portfolio | Small-Cap Growth | 19,400 | Sold Some | -7,700 | -28.41 % | $132,114 | $143,560 | $11,446 | 8.66 % | $-4,543 | | | | | | News Article | History of Axa Premier Vip Trust-Multimanager Small Cap Growth Portfolio Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust-Eqalliancebernstein Small Cap Growth Portfolio | Small-Cap Growth | 19,600 | No Change | 0 | 0 % | $133,476 | $145,040 | $11,564 | 8.66 % | $0 | | | | | | News Article | History of Eq Advisors Trust-Eqalliancebernstein Small Cap Growth Portfolio Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust-Eqalliancebernstein Value Portfolio | Multi-Cap Value | 6,600 | New Holding | 6,600 | 100 % | $44,946 | $48,840 | $3,894 | 8.66 % | $3,894 | | | | | | News Article | History of Eq Advisors Trust-Eqalliancebernstein Value Portfolio Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust-Eqbond Index Portfolio | Specialty & Misc | 43,460 | Added More | 3,860 | 9.74 % | $295,963 | $321,604 | $25,641 | 8.66 % | $2,277 | | | | | | News Article | History of Eq Advisors Trust-Eqbond Index Portfolio Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust I-Jpmorgan Japan Fund | Japanese | | Sold All | -4 | -100 % | | | | 8.66 % | $-2 | | | | | | News Article | History of Jpmorgan Trust I-Jpmorgan Japan Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust I-Jpmorgan Prime Money Market Fund | Specialty & Misc | 54 | New Holding | 54 | 100 % | $368 | $400 | $32 | 8.66 % | $32 | | | | | | News Article | History of Jpmorgan Trust I-Jpmorgan Prime Money Market Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust I-Jpmorgan Small Cap Core Fund | Small-Cap Core | 70 | Added More | 9 | 14.75 % | $477 | $518 | $41 | 8.66 % | $5 | | | | | | News Article | History of Jpmorgan Trust I-Jpmorgan Small Cap Core Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust Ii-Jpmorgan Core Bond Fund | Multi-Cap Core | 70 | Added More | 11 | 18.64 % | $477 | $518 | $41 | 8.66 % | $6 | | | | | | News Article | History of Jpmorgan Trust Ii-Jpmorgan Core Bond Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust Ii-Jpmorgan Small Cap Value Fund | Small-Cap Value | 48 | Added More | 39 | 433.33 % | $327 | $355 | $28 | 8.66 % | $23 | | | | | | News Article | History of Jpmorgan Trust Ii-Jpmorgan Small Cap Value Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Profunds-Bull Profund | Large-Cap Core | 749 | New Holding | 749 | 100 % | $5,101 | $5,543 | $442 | 8.66 % | $442 | | | | | | News Article | History of Profunds-Bull Profund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Un Capital Advisers Trust-Sc Oppenheimer Main Street Small Cap Fund | Small-Cap Core | 5,700 | Added More | 200 | 3.63 % | $38,817 | $42,180 | $3,363 | 8.66 % | $118 | | | | | | News Article | History of Un Capital Advisers Trust-Sc Oppenheimer Main Street Small Cap Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Vanguard Institutional Index Funds-Vanguard Institutional Index Fund | Specialty & Misc | 27,200 | New Holding | 27,200 | 100 % | $185,232 | $201,280 | $16,048 | 8.66 % | $16,048 | | | | | | News Article | History of Vanguard Institutional Index Funds-Vanguard Institutional Index Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mml Series Investment Fund Ii-Mml Small Cap Equity Fund | Small-Cap Core | 4,890 | Added More | 1,860 | 61.38 % | | $36,186 | | - % | | | | | | | News Article | History of Mml Series Investment Fund Ii-Mml Small Cap Equity Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund-Pd Small-Cap Growth Index Portfolio | No Data | 622 | No Compare | | | | $4,603 | | - % | | | | | | | News Article | History of Pacific Select Fund-Pd Small-Cap Growth Index Portfolio Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSR | Treettracks Series Trust-Spdr Dividend Etf | Specialty & Misc | | Sold All | -6,046 | -100 % | | | | - % | | | | | | | News Article | History of Treettracks Series Trust-Spdr Dividend Etf Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | N-Q/A | Rydex Series Funds-Biotechnology Fund | Health/Biotech | 113,435 | Added More | 23,612 | 26.28 % | $753,208 | $839,419 | $86,211 | 11.44 % | $17,945 | | | | | | News Article | History of Rydex Series Funds-Biotechnology Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Tiaa Cref Life Fund-Stock Index Fund | Specialty & Misc | 517 | No Change | 0 | 0 % | $3,645 | $3,826 | $181 | 4.96 % | $0 | | | | | | News Article | History of Tiaa Cref Life Fund-Stock Index Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-CSRS | Columbia Funds Variable Insurance Trust-Columbia Asset Allocation Fund Variable Serie | Specialty & Misc | 930 | Sold Some | -50 | -5.10 % | $6,770 | $6,882 | $112 | 1.64 % | $-6 | | | | | | News Article | History of Columbia Funds Variable Insurance Trust-Columbia Asset Allocation Fund Variable Serie Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-CSRS | Columbia Funds Variable Insurance Trust-Columbia Small Company Growth Fund Variable Serie | Small-Cap Growth | 16,950 | Sold Some | -1,190 | -6.56 % | $123,396 | $125,430 | $2,034 | 1.64 % | $-143 | | | | | | News Article | History of Columbia Funds Variable Insurance Trust-Columbia Small Company Growth Fund Variable Serie Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust-Ishares Nasdaq Biotechnology Index Fund | Health/Biotech | 348,814 | Sold Some | -16,830 | -4.60 % | $2,539,366 | $2,581,224 | $41,858 | 1.64 % | $-2,020 | | | | | | News Article | History of Ishares Trust-Ishares Nasdaq Biotechnology Index Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust-Ishares Russell 2000 Growth Index Fund | Multi-Cap Growth | 259,813 | Added More | 10,711 | 4.29 % | $1,891,439 | $1,922,616 | $31,178 | 1.64 % | $1,285 | | | | | | News Article | History of Ishares Trust-Ishares Russell 2000 Growth Index Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust-Ishares Russell 2000 Index Fund | Specialty & Misc | 442,542 | Sold Some | -10,647 | -2.34 % | $3,221,706 | $3,274,811 | $53,105 | 1.64 % | $-1,278 | | | | | | News Article | History of Ishares Trust-Ishares Russell 2000 Index Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust-Ishares Russell 3000 Growth Index Fund | Multi-Cap Growth | 2,131 | Sold Some | -231 | -9.77 % | $15,514 | $15,769 | $256 | 1.64 % | $-28 | | | | | | News Article | History of Ishares Trust-Ishares Russell 3000 Growth Index Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust-Ishares Russell 3000 Index Fund | Specialty & Misc | 9,531 | Added More | 540 | 6.00 % | $69,386 | $70,529 | $1,144 | 1.64 % | $65 | | | | | | News Article | History of Ishares Trust-Ishares Russell 3000 Index Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Leuthold Funds Inc-Leuthold Core Investment Fund | Flexible Portfolio | 194,511 | Sold Some | -147 | -0.07 % | $1,464,668 | $1,439,381 | $-25,286 | -1.72 % | $19 | | | | | | News Article | History of Leuthold Funds Inc-Leuthold Core Investment Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Leuthold Funds Inc-Leuthold Select Industries Fund | Specialty Dvsfd Eq | 11,825 | Added More | 475 | 4.18 % | $89,042 | $87,505 | $-1,537 | -1.72 % | $-62 | | | | | | News Article | History of Leuthold Funds Inc-Leuthold Select Industries Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds-Equity Index Fund | Specialty & Misc | 23,883 | Added More | 14,663 | 159.03 % | $179,839 | $176,734 | $-3,105 | -1.72 % | $-1,906 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds-Equity Index Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds-Growth Equity Fund | Multi-Cap Growth | | Sold All | -13,287 | -100 % | | | | -1.72 % | $1,727 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds-Growth Equity Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds-Vanguard Extended Market Index Fund | Mid-Cap Core | 224,380 | New Holding | 224,380 | 100 % | $1,689,581 | $1,660,412 | $-29,169 | -1.72 % | $-29,169 | | | | | | News Article | History of Vanguard Index Funds-Vanguard Extended Market Index Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds-Vanguard Growth Index Fund | Large-Cap Growth | 184,208 | New Holding | 184,208 | 100 % | $1,387,086 | $1,363,139 | $-23,947 | -1.72 % | $-23,947 | | | | | | News Article | History of Vanguard Index Funds-Vanguard Growth Index Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds-Vanguard Total Stock Market Index Fund | Multi-Cap Core | 339,011 | New Holding | 339,011 | 100 % | $2,552,753 | $2,508,681 | $-44,071 | -1.72 % | $-44,071 | | | | | | News Article | History of Vanguard Index Funds-Vanguard Total Stock Market Index Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds-Vanguard Value Index Fund | Large-Cap Value | 101,995 | New Holding | 101,995 | 100 % | $768,022 | $754,763 | $-13,259 | -1.72 % | $-13,259 | | | | | | News Article | History of Vanguard Index Funds-Vanguard Value Index Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds-Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 10,989 | No Change | 0 | 0 % | $82,747 | $81,319 | $-1,429 | -1.72 % | $0 | | | | | | News Article | History of Vanguard Balanced Index Funds-Vanguard Balanced Index Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds-Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 15,889 | Added More | 4,900 | 44.59 % | $119,644 | $117,579 | $-2,066 | -1.72 % | $-637 | | | | | | News Article | History of Vanguard Balanced Index Funds-Vanguard Balanced Index Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-25 | 2009-06-30 | N-Q | Nicholas Applegate Institutional Funds-International Growth Fund | Multi-Cap Growth | 6,500 | New Holding | 6,500 | 100 % | $51,740 | $48,100 | $-3,640 | -7.03 % | $-3,640 | | | | | | News Article | History of Nicholas Applegate Institutional Funds-International Growth Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-25 | 2009-06-30 | N-Q | Oppenheimer Global Opportunities Fund-Oppenheimer Global Opportunities Fund | Global Flex Port | | Sold All | -3,500,000 | -100 % | | | | -7.03 % | $1,960,000 | | | | | | News Article | History of Oppenheimer Global Opportunities Fund-Oppenheimer Global Opportunities Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-24 | 2009-06-30 | N-CSRS | Oppenheimer Variable Account Funds-Oppenheimer Main Street Fundva | Specialty & Misc | 27,800 | New Holding | 27,800 | 100 % | $223,512 | $205,720 | $-17,792 | -7.96 % | $-17,792 | | | | | | News Article | History of Oppenheimer Variable Account Funds-Oppenheimer Main Street Fundva Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-21 | 2009-06-30 | N-CSRS | Dws Variable Series I-Dws Health Care Vip | Health/Biotech | 10,700 | Sold Some | -600 | -5.30 % | $89,452 | $79,180 | $-10,272 | -11.48 % | $576 | | | | | | News Article | History of Dws Variable Series I-Dws Health Care Vip Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-21 | 2009-06-30 | N-CSR | Oppenheimer Main Street Small Cap Fund-Oppenheimer Main Street Small Cap Fund | Small-Cap Core | 118,493 | New Holding | 118,493 | 100 % | $990,601 | $876,848 | $-113,753 | -11.48 % | $-113,753 | | | | | | News Article | History of Oppenheimer Main Street Small Cap Fund-Oppenheimer Main Street Small Cap Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-18 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 2,072,517 | Sold Some | -14,722 | -0.70 % | $16,352,159 | $15,336,626 | $-1,015,533 | -6.21 % | $7,214 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-18 | 2009-06-30 | 13F-HR | Us Bancorp De | Institution | 22,689 | Added More | 20,217 | 817.83 % | $179,016 | $167,899 | $-11,118 | -6.21 % | $-9,906 | | | | | | News Article | History of Us Bancorp De Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Morgan Stanley | Institution | 1,466,141 | Sold Some | -375,895 | -20.40 % | $11,538,530 | $10,849,443 | $-689,086 | -5.97 % | $176,671 | | | | | | News Article | History of Morgan Stanley Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Adage Capital Partners Gp Llc | Institution | 625,707 | No Change | 0 | 0 % | $5,155,826 | $4,630,232 | $-525,594 | -10.19 % | $0 | | | | | | News Article | History of Adage Capital Partners Gp Llc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | American International Group Inc | Institution | 29,716 | Added More | 57 | 0.19 % | $244,860 | $219,898 | $-24,961 | -10.19 % | $-48 | | | | | | News Article | History of American International Group Inc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Axa | Institution | 65,760 | Sold Some | -1,140 | -1.70 % | $541,862 | $486,624 | $-55,238 | -10.19 % | $958 | | | | | | News Article | History of Axa Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Bam Management Llc | No Data | | Sold All | -66,860 | -100 % | | | | -10.19 % | $56,162 | | | | | | News Article | History of Bam Management Llc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Black River Asset Management Llc | Institution | 7,600 | New Holding | 7,600 | 100 % | $62,624 | $56,240 | $-6,384 | -10.19 % | $-6,384 | | | | | | News Article | History of Black River Asset Management Llc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Bridgeway Capital Management Inc | Institution | 54,462 | Sold Some | -3,700 | -6.36 % | $448,767 | $403,019 | $-45,748 | -10.19 % | $3,108 | | | | | | News Article | History of Bridgeway Capital Management Inc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Capital Guardian Trust Co | Institution | 46 | No Change | 0 | 0 % | $379 | $340 | $-39 | -10.19 % | $0 | | | | | | News Article | History of Capital Guardian Trust Co Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Citadel L P | Institution | 108,193 | Added More | 105,006 | 3294.82 % | $891,510 | $800,628 | $-90,882 | -10.19 % | $-88,205 | | | | | | News Article | History of Citadel L P Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Deerfield Management Co | Institution | 2,539,086 | Sold Some | -1,082,001 | -29.88 % | $20,922,069 | $18,789,236 | $-2,132,832 | -10.19 % | $908,881 | | | | | | News Article | History of Deerfield Management Co Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Driehaus Capital Management Llc | Institution | 83,644 | New Holding | 83,644 | 100 % | $689,227 | $618,966 | $-70,261 | -10.19 % | $-70,261 | | | | | | News Article | History of Driehaus Capital Management Llc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Employees Retirement System Of Texa | Institution | | Sold All | -34,000 | -100 % | | | | -10.19 % | $28,560 | | | | | | News Article | History of Employees Retirement System Of Texa Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Fidelity International Ltd | Institution | 2,170 | New Holding | 2,170 | 100 % | $17,881 | $16,058 | $-1,823 | -10.19 % | $-1,823 | | | | | | News Article | History of Fidelity International Ltd Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Fmr Corp | Institution | 5,343,510 | Sold Some | -143,920 | -2.62 % | $44,030,522 | $39,541,974 | $-4,488,548 | -10.19 % | $120,893 | | | | | | News Article | History of Fmr Corp Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Geode Capital Management Llc | Institution | 115,057 | Added More | 48,032 | 71.66 % | $948,070 | $851,422 | $-96,648 | -10.19 % | $-40,347 | | | | | | News Article | History of Geode Capital Management Llc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Goldman Sachs Group Inc | Institution | 192,949 | Sold Some | -89,586 | -31.70 % | $1,589,900 | $1,427,823 | $-162,077 | -10.19 % | $75,252 | | | | | | News Article | History of Goldman Sachs Group Inc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Haw D E And Co Inc | Institution | 3,359,874 | Added More | 301,147 | 9.84 % | $27,685,362 | $24,863,068 | $-2,822,294 | -10.19 % | $-252,963 | | | | | | News Article | History of Haw D E And Co Inc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Ing Groep Nv | Institution | 71,150 | New Holding | 71,150 | 100 % | $586,276 | $526,510 | $-59,766 | -10.19 % | $-59,766 | | | | | | News Article | History of Ing Groep Nv Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Jacobs Levy Equity Management Inc | Institution | | Sold All | -30,446 | -100 % | | | | -10.19 % | $25,575 | | | | | | News Article | History of Jacobs Levy Equity Management Inc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Jay Jeffrey R | Institution | 100,000 | New Holding | 100,000 | 100 % | $824,000 | $740,000 | $-84,000 | -10.19 % | $-84,000 | | | | | | News Article | History of Jay Jeffrey R Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Jefferies Group Inc | Institution | 21,700 | New Holding | 21,700 | 100 % | $178,808 | $160,580 | $-18,228 | -10.19 % | $-18,228 | | | | | | News Article | History of Jefferies Group Inc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Jesaga Advisers Llc | Institution | 79,300 | New Holding | 79,300 | 100 % | $653,432 | $586,820 | $-66,612 | -10.19 % | $-66,612 | | | | | | News Article | History of Jesaga Advisers Llc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Kbc Group Nv | Institution | 335 | No Change | 0 | 0 % | $2,760 | $2,479 | $-281 | -10.19 % | $0 | | | | | | News Article | History of Kbc Group Nv Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Labranche And Co Inc | Institution | 18,267 | Sold Some | -20,685 | -53.10 % | $150,520 | $135,176 | $-15,344 | -10.19 % | $17,375 | | | | | | News Article | History of Labranche And Co Inc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Leuthold Weeden Capital Management Llc | Institution | 336,786 | Sold Some | -1,246 | -0.36 % | $2,775,117 | $2,492,216 | $-282,900 | -10.19 % | $1,047 | | | | | | News Article | History of Leuthold Weeden Capital Management Llc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Marshall Wace North America L P | Institution | 12,060 | New Holding | 12,060 | 100 % | $99,374 | $89,244 | $-10,130 | -10.19 % | $-10,130 | | | | | | News Article | History of Marshall Wace North America L P Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Merrill Lynch And Co Inc | Institution | 8,482 | New Holding | 8,482 | 100 % | $69,892 | $62,767 | $-7,125 | -10.19 % | $-7,125 | | | | | | News Article | History of Merrill Lynch And Co Inc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Millennium Management Llc | Institution | 54,368 | Sold Some | -162,802 | -74.96 % | $447,992 | $402,323 | $-45,669 | -10.19 % | $136,754 | | | | | | News Article | History of Millennium Management Llc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Northern Trust Corp | Institution | 410,030 | Added More | 72,839 | 21.60 % | $3,378,647 | $3,034,222 | $-344,425 | -10.19 % | $-61,185 | | | | | | News Article | History of Northern Trust Corp Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Oppenheimer Funds Inc | Institution | 3,677,053 | Sold Some | -13,820 | -0.37 % | $30,298,917 | $27,210,192 | $-3,088,725 | -10.19 % | $11,609 | | | | | | News Article | History of Oppenheimer Funds Inc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Palo Alto Investors Llc | Institution | 257,512 | No Change | 0 | 0 % | $2,121,899 | $1,905,589 | $-216,310 | -10.19 % | $0 | | | | | | News Article | History of Palo Alto Investors Llc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Perceptive Advisors Llc | Institution | 100,000 | New Holding | 100,000 | 100 % | $824,000 | $740,000 | $-84,000 | -10.19 % | $-84,000 | | | | | | News Article | History of Perceptive Advisors Llc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Price T Rowe Associates Inc | Institution | 276,700 | Sold Some | -2,300 | -0.82 % | $2,280,008 | $2,047,580 | $-232,428 | -10.19 % | $1,932 | | | | | | News Article | History of Price T Rowe Associates Inc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Rbc Dain Rauscher Inc | Institution | 222 | No Change | 0 | 0 % | $1,829 | $1,643 | $-186 | -10.19 % | $0 | | | | | | News Article | History of Rbc Dain Rauscher Inc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Td Asset Management Inc | Institution | 15,300 | No Change | 0 | 0 % | $126,072 | $113,220 | $-12,852 | -10.19 % | $0 | | | | | | News Article | History of Td Asset Management Inc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Vanguard Group Inc | Institution | 1,402,100 | Added More | 83,796 | 6.35 % | $11,553,304 | $10,375,540 | $-1,177,764 | -10.19 % | $-70,389 | | | | | | News Article | History of Vanguard Group Inc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Wellington Management Co Llp | Institution | 4,102,417 | Sold Some | -372,300 | -8.32 % | $33,803,916 | $30,357,886 | $-3,446,030 | -10.19 % | $312,732 | | | | | | News Article | History of Wellington Management Co Llp Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Ameriprise Financial Inc | Institution | 51,154 | Sold Some | -3,000 | -5.53 % | $440,947 | $378,540 | $-62,408 | -14.15 % | $3,660 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Bank Of New York Mellon Corp | Institution | 197,271 | Sold Some | -10,194 | -4.91 % | $1,700,476 | $1,459,805 | $-240,671 | -14.15 % | $12,437 | | | | | | News Article | History of Bank Of New York Mellon Corp Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Barclays Plc | Institution | 1,313 | Sold Some | -67,819 | -98.10 % | $11,318 | $9,716 | $-1,602 | -14.15 % | $82,739 | | | | | | News Article | History of Barclays Plc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Federated Investors Inc | Institution | 278,085 | Added More | 145,800 | 110.21 % | $2,397,093 | $2,057,829 | $-339,264 | -14.15 % | $-177,876 | | | | | | News Article | History of Federated Investors Inc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Fortis Investments Management Usa Inc | Institution | 49,642 | New Holding | 49,642 | 100 % | $427,914 | $367,351 | $-60,563 | -14.15 % | $-60,563 | | | | | | News Article | History of Fortis Investments Management Usa Inc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Hsbc Holdings Plc | Institution | | Sold All | -15,500 | -100 % | | | | -14.15 % | $18,910 | | | | | | News Article | History of Hsbc Holdings Plc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Ing Investment Management Co | Institution | 12,150 | Added More | 700 | 6.11 % | $104,733 | $89,910 | $-14,823 | -14.15 % | $-854 | | | | | | News Article | History of Ing Investment Management Co Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | J P Morgan Chase And Co | Institution | 232,975 | Added More | 63,646 | 37.58 % | $2,008,245 | $1,724,015 | $-284,230 | -14.15 % | $-77,648 | | | | | | News Article | History of J P Morgan Chase And Co Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Ubs Ag | Institution | 5,000 | Added More | 2,938 | 142.48 % | $43,100 | $37,000 | $-6,100 | -14.15 % | $-3,584 | | | | | | News Article | History of Ubs Ag Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Wells Fargo And Co | Institution | 1,172 | Sold Some | -1,700 | -59.19 % | $10,103 | $8,673 | $-1,430 | -14.15 % | $2,074 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Wexford Capital Llc | Institution | | Sold All | -28,844 | -100 % | | | | -14.15 % | $35,190 | | | | | | News Article | History of Wexford Capital Llc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-12 | 2009-06-30 | 13F-HR | Allianz Global Investors Of America L P | Institution | 197,100 | New Holding | 197,100 | 100 % | $1,697,031 | $1,458,540 | $-238,491 | -14.05 % | $-238,491 | | | | | | News Article | History of Allianz Global Investors Of America L P Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-12 | 2009-06-30 | 13F-HR | Credit Suisse First Boston | Institution | 44,520 | Added More | 31,069 | 230.97 % | $383,317 | $329,448 | $-53,869 | -14.05 % | $-37,593 | | | | | | News Article | History of Credit Suisse First Boston Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-12 | 2009-06-30 | 13F-HR | Dafna Capital Management Llc | Institution | 167,479 | Added More | 67,479 | 67.47 % | $1,441,994 | $1,239,345 | $-202,650 | -14.05 % | $-81,650 | | | | | | News Article | History of Dafna Capital Management Llc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-12 | 2009-06-30 | 13F-HR/A | Duquesne Capital Management L L C | Institution | 900,000 | Added More | 200,000 | 28.57 % | $7,749,000 | $6,660,000 | $-1,089,000 | -14.05 % | $-242,000 | | | | | | News Article | History of Duquesne Capital Management L L C Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-12 | 2009-06-30 | 13F-HR | Usquehanna International Group Llp | Institution | 30,165 | Sold Some | -65,005 | -68.30 % | $259,721 | $223,221 | $-36,500 | -14.05 % | $78,656 | | | | | | News Article | History of Usquehanna International Group Llp Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-11 | 2009-06-30 | 13F-HR | Alphabet Management Llc | No Data | 11,455 | New Holding | 11,455 | 100 % | $95,077 | $84,767 | $-10,310 | -10.84 % | $-10,310 | | | | | | News Article | History of Alphabet Management Llc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-11 | 2009-06-30 | 13F-HR | Amvescap Plc | Institution | 360,108 | Sold Some | -596,484 | -62.35 % | $2,988,896 | $2,664,799 | $-324,097 | -10.84 % | $536,836 | | | | | | News Article | History of Amvescap Plc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-11 | 2009-06-30 | 13F-HR | Blackrock Inc | No Data | 208,446 | Sold Some | -149,254 | -41.72 % | $1,730,102 | $1,542,500 | $-187,601 | -10.84 % | $134,329 | | | | | | News Article | History of Blackrock Inc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-11 | 2009-06-30 | 13F-HR | Padco Advisors Ii Inc | Institution | 18,497 | Sold Some | -10,412 | -36.01 % | $153,525 | $136,878 | $-16,647 | -10.84 % | $9,371 | | | | | | News Article | History of Padco Advisors Ii Inc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-11 | 2009-06-30 | 13F-HR | Padco Advisors Inc | Institution | 114,421 | Added More | 22,812 | 24.90 % | $949,694 | $846,715 | $-102,979 | -10.84 % | $-20,531 | | | | | | News Article | History of Padco Advisors Inc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-11 | 2009-06-30 | 13F-HR | Trilogy Global Advisors Llc | Institution | | Sold All | -44,632 | -100 % | | | | -10.84 % | $40,169 | | | | | | News Article | History of Trilogy Global Advisors Llc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-11 | 2009-06-30 | 13F-HR | Ubs Global Asset Management Americas Inc | Institution | 124,500 | Sold Some | -80,736 | -39.33 % | $1,033,350 | $921,300 | $-112,050 | -10.84 % | $72,662 | | | | | | News Article | History of Ubs Global Asset Management Americas Inc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-10 | 2009-06-30 | 13F-HR | Bank Of Hawaii | Institution | 25,389 | Sold Some | -14,400 | -36.19 % | $218,853 | $187,879 | $-30,975 | -14.15 % | $17,568 | | | | | | News Article | History of Bank Of Hawaii Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-10 | 2009-06-30 | 13F-HR | Bb Biotech Ag | Institution | 170,000 | Sold Some | -200,000 | -54.05 % | $1,465,400 | $1,258,000 | $-207,400 | -14.15 % | $244,000 | | | | | | News Article | History of Bb Biotech Ag Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-10 | 2009-06-30 | 13F-HR | Dimensional Fund Advisors Inc | Institution | 618,231 | Added More | 4,500 | 0.73 % | $5,329,151 | $4,574,909 | $-754,242 | -14.15 % | $-5,490 | | | | | | News Article | History of Dimensional Fund Advisors Inc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-10 | 2009-06-30 | 13F-HR | Mfc Global Investment Management Usa Ltd | Institution | 32,796 | Sold Some | -5,619 | -14.62 % | $282,702 | $242,690 | $-40,011 | -14.15 % | $6,855 | | | | | | News Article | History of Mfc Global Investment Management Usa Ltd Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-10 | 2009-06-30 | 13F-HR | Uffolk Capital Management Llc | Institution | 40,000 | New Holding | 40,000 | 100 % | $344,800 | $296,000 | $-48,800 | -14.15 % | $-48,800 | | | | | | News Article | History of Uffolk Capital Management Llc Ownership Of Rigel Pharmaceuticals Inc |
RSS feed for RIGL